The Catalan pharmaceutical company Uriach will exceed the revenue projections included in its 2020-2025 strategic plan, which called for reaching €500 million this year. The family-owned company achieved revenue of €476 million last year, a 54% increase over the previous year, thanks to acquisitions made in Europe to lead the self-consumption pharmaceutical business based on natural ingredients.